Purabi General Insurance Company Limited (DSE:PURABIGEN)
Bangladesh · Delayed Price · Currency is BDT 32.30
-0.20 (-0.62%)
At close: Aug 13, 2026
DSE:PURABIGEN Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 170.1 | 114.28 | 133.69 | - | 57.9 | 81.85 |
Total Interest & Dividend Income | 87.37 | 102.58 | 88.94 | 103.33 | 91.77 | 64.66 |
Gain (Loss) on Sale of Investments | -0.35 | -0.35 | -1.71 | 5.56 | 11.99 | 16.68 |
Other Revenue | 19.71 | 19.75 | 18.8 | - | 18.66 | 12.42 |
| 276.82 | 236.26 | 239.72 | 108.89 | 180.33 | 175.61 | |
Revenue Growth | 27.41% | -1.44% | 120.15% | -39.62% | 2.69% | 43.92% |
Policy Benefits | 75.43 | 45.04 | 24.65 | - | -4.37 | 24.04 |
Policy Acquisition & Underwriting Costs | 29.2 | 23.26 | 21.1 | - | 17.19 | 5.64 |
Depreciation & Amortization | 4.54 | 4.54 | 3.98 | 2.01 | 1.51 | 0.91 |
Selling, General & Administrative | 51.55 | 52.93 | 49.66 | 3.6 | 35.91 | 28.19 |
Total Operating Expenses | 160.71 | 125.78 | 99.39 | 5.61 | 50.25 | 58.77 |
Operating Income | 116.11 | 110.48 | 140.33 | 103.28 | 130.08 | 116.83 |
Interest Expense | -0.65 | -0.65 | -0.81 | -0.65 | -4.97 | -1.39 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.15 |
EBT Excluding Unusual Items | 115.46 | 109.83 | 139.52 | 102.63 | 125.11 | 115.29 |
Gain (Loss) on Sale of Assets | - | - | 0.11 | 0.28 | - | - |
Pretax Income | 115.46 | 109.83 | 139.63 | 102.91 | 125.11 | 115.29 |
Income Tax Expense | 39.73 | 37.55 | 47.79 | 31.98 | 41.41 | 35.57 |
Net Income | 75.72 | 72.28 | 91.84 | 70.92 | 83.71 | 79.72 |
Net Income to Common | 75.72 | 72.28 | 91.84 | 70.92 | 83.71 | 79.72 |
Net Income Growth | -10.77% | -21.29% | 29.49% | -15.27% | 4.99% | 24.62% |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 | 60 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 | 60 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 1.27 | 1.21 | 1.54 | 1.19 | 1.40 | 1.33 |
EPS (Diluted) | 1.27 | 1.21 | 1.54 | 1.19 | 1.40 | 1.33 |
EPS Growth | -10.77% | -21.29% | 29.49% | -15.27% | 4.99% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 97.45 | 79.31 | 86.74 | 64.51 | 210.48 | 61.71 |
Free Cash Flow Per Share | 1.63 | 1.33 | 1.45 | 1.08 | 3.52 | 1.03 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 0.680 | 0.971 |
Dividend Growth | 0% | 0% | 0% | 47.14% | -30.00% | 100.02% |
Operating Margin | 41.94% | 46.76% | 58.54% | 94.85% | 72.14% | 66.53% |
Profit Margin | 27.36% | 30.60% | 38.31% | 65.14% | 46.42% | 45.40% |
Free Cash Flow Margin | 35.20% | 33.57% | 36.18% | 59.25% | 116.72% | 35.14% |
EBITDA | 118.45 | 112.97 | 144.31 | 105.29 | 131.59 | 117.74 |
EBITDA Margin | 42.79% | 47.82% | 60.20% | 96.69% | 72.97% | 67.05% |
D&A For EBITDA | 2.34 | 2.49 | 3.98 | 2.01 | 1.51 | 0.91 |
EBIT | 116.11 | 110.48 | 140.33 | 103.28 | 130.08 | 116.83 |
EBIT Margin | 41.94% | 46.76% | 58.54% | 94.85% | 72.14% | 66.53% |
Effective Tax Rate | 34.41% | 34.19% | 34.23% | 31.08% | 33.09% | 30.85% |